121 related articles for article (PubMed ID: 2184571)
1. [Tumor markers and prognostic parameters in urinary bladder cancer].
Schneider AW; Huland H
Urologe A; 1990 Mar; 29(2):71-6. PubMed ID: 2184571
[TBL] [Abstract][Full Text] [Related]
2. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic methods in the diagnosis of invasive bladder cancer.
Krause FS; Feil G; Zumbrägel A; Bichler KH
Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
Bittard H; Lamy B; Billery C
J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
[TBL] [Abstract][Full Text] [Related]
7. [Molecular biology studies of bladder cancer].
Bringuier PP; Knopf HJ; Schalken JA; Debruyne FM
Urologe A; 1991 May; 30(3):167-71. PubMed ID: 1871935
[TBL] [Abstract][Full Text] [Related]
8. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
[TBL] [Abstract][Full Text] [Related]
9. Urothelial cancer biomarkers for detection and surveillance.
Liou LS
Urology; 2006 Mar; 67(3 Suppl 1):25-33; discussion 33-4. PubMed ID: 16530072
[TBL] [Abstract][Full Text] [Related]
10. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
Hosaka Y
Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
12. Advances in the diagnosis of urothelial neoplasia.
Crissman JD; Zarbo RJ; Johnson T; Babu VR; Sarkar FH; Miles BJ; Cerny JC
Henry Ford Hosp Med J; 1989; 37(1):19-23. PubMed ID: 2670840
[TBL] [Abstract][Full Text] [Related]
13. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.
Casella R; Huber P; Blöchlinger A; Stoffel F; Dalquen P; Gasser TC; Lehmann K
J Urol; 2000 Dec; 164(6):1926-8. PubMed ID: 11061883
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometry in diagnosis and treatment of bladder tumor].
Sun XJ; Song ZL; Wu DC
Zhonghua Wai Ke Za Zhi; 1994 Mar; 32(3):178-80. PubMed ID: 7842912
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic markers as promising prognosticators for bladder cancer.
Kim YK; Kim WJ
Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
[TBL] [Abstract][Full Text] [Related]
17. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
18. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
Sibony M; Billerey C
Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
[TBL] [Abstract][Full Text] [Related]
19. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
20. [Use of flow cytometry in the diagnosis of bladder tumor].
Ling CH
Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):286-8, 317. PubMed ID: 2806005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
